| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel and Secretary
2 companies
Meisner Lara is a Chief Legal Officer at VRDN, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 19 sales. Those positions are worth an estimated $850K at current prices.
Our model assigns Meisner Lara a strong insider score of 71/100, based on 18 past trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +25.2%.
Meisner Lara's largest disclosed position is in VRDN as Chief Legal Officer, worth about $850K. The recent filings there lean toward selling, a net 89,514 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | BCAX Bicara Therapeutics Inc. | Chief Legal Officer | Sale+OE10b5-1 | 33,807 | $14.75 | $498,653.25 | - | +19.0% | +33.8% | |
| Sep 15, 2025 | BCAX Bicara Therapeutics Inc. | Chief Legal Officer | Sale+OE10b5-1 | 15,829 | $11.49 | $181,875.21 | - | +61.3% | +99.2% | |
| Jun 16, 2025 | BCAX Bicara Therapeutics Inc. | Chief Legal Officer | Sale+OE10b5-1 | 15,829 | $10.43 | $165,096.47 | - | +13.8% | +119.5% | |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | Chief Legal Officer | Sale+OE10b5-1 | 79,146 | $12.90 | $1,021,210.80 | - | -6.8% | +54.5% | |
| Jun 16, 2023 | VRDN Viridian Therapeutics, Inc.\de | Chief Legal Officer | Sale+OE | 2,296 | $28.02 | $64,342.83 | -7.1% | -35.4% | -54.1% | |
| Jun 6, 2023 | VRDN Viridian Therapeutics, Inc.\de | Chief Legal Officer | Sale+OE10b5-1 | 7,500 | $24.82 | $186,136.24 | -20.0% | -22.6% | -50.6% | |
| Mar 9, 2023 | VRDN Viridian Therapeutics, Inc.\de | General Counsel and Secretary | Sell | 29,971 | $29.07 | $871,256.97 | -100% | -14.2% | -34.7% | |
| Jan 23, 2023 | VRDN Viridian Therapeutics, Inc.\de | General Counsel and Secretary | Sale+OE | 6,843 | $35.66 | $244,021.38 | - | -18.4% | -46.9% | |
| Dec 21, 2022 | VRDN Viridian Therapeutics, Inc.\de | General Counsel and Secretary | Sale+OE | 16,926 | $29.15 | $493,397.94 | - | -9.5% | -27.7% | |
| Dec 16, 2022 | VRDN Viridian Therapeutics, Inc.\de | General Counsel and Secretary | Sale+OE | 1,597 | $28.37 | $45,310.68 | - | +2.6% | -31.1% |